| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 12 | -671,101 | 100% | $66.08 | -$44,346,213 |
| Net | -12 | -671,101 | -100% | -$44,346,213 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Matthew B. Klein | CHIEF EXECUTIVE OFFICER, Director | $35,507,576 | -$2,177,749 | -5.8% | 02 Jan 2026 |
| MICHAEL SCHMERTZLER | Director | $12,877,765 | 02 Jan 2026 | ||
| Stuart Walter Peltz | CHIEF EXECUTIVE OFFICER, Director | $10,876,127 | 31 Jan 2023 | ||
| Neil Gregory Almstead | Chief Technical Ops Officer | $10,805,548 | -$12,768,242 | -54% | 02 Jan 2026 |
| Mark Elliott Boulding | Exec. Vp And Clo | $9,283,987 | -$10,531,564 | -53% | 02 Jan 2026 |
| Lee Scott Golden | Evp & Chief Medical Officer | $8,589,664 | -$220,196 | -2.5% | 02 Jan 2026 |
| Pierre Gravier | Chief Financial Officer | $8,543,989 | -$241,448 | -2.7% | 02 Jan 2026 |
| Eric Pauwels | Chief Business Officer | $8,372,004 | -$8,077,231 | -49% | 02 Jan 2026 |
| Christine Marie Utter | Svp, Chief Accounting Officer | $6,745,764 | -$220,536 | -3.2% | 02 Jan 2026 |
| Emily Luisa Hill | Chief Financial Officer | $2,215,407 | 27 Mar 2023 | ||
| JEROME B. ZELDIS | Director | $1,947,140 | 02 Jan 2026 | ||
| GLENN JR STEELE | Director | $1,947,140 | -$916,200 | -32% | 02 Jan 2026 |
| Mary L. Smith | Director | $1,894,955 | 02 Jan 2026 | ||
| Allan Steven Jacobson | Director | $1,867,457 | -$3,058,988 | -62% | 02 Jan 2026 |
| Alethia Young | Director | $1,838,289 | 02 Jan 2026 | ||
| DAVID P. SOUTHWELL | Director | $1,821,806 | -$700,080 | -28% | 02 Jan 2026 |
| Stephanie Okey | Director | $1,149,560 | -$270,000 | -19% | 02 Jan 2026 |
| Dawn Svoronos | Director | $1,119,097 | 09 Jun 2022 | ||
| Emma Reeve | Director | $1,048,656 | -$5,163,979 | -83% | 02 Jan 2026 |
| William F. Bell Jr. | Director | $552,083 | 15 Feb 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|